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Long-term hematopoietic stem cells (LT-HSCs)
maintain hematopoietic output throughout an ani-
mal’s lifespan. However, with age, the balance is
disrupted, and LT-HSCs produce a myeloid-biased
output, resulting in poor immune responses to infec-
tious challenge and the development of myeloid
leukemias. Here, we show that young and aged
LT-HSCs respond differently to inflammatory stress,
such that aged LT-HSCs produce a cell-intrinsic,
myeloid-biased expression program. Using single-
cell RNA sequencing (scRNA-seq), we identify a
myeloid-biased subset within the LT-HSC population
(mLT-HSCs) that is prevalent among aged LT-HSCs.
We identify CD61 as a marker of mLT-HSCs and
show that CD61-high LT-HSCs are uniquely primed
to respond to acute inflammatory challenge. We pre-
dict that several transcription factors regulate the
mLT-HSCs gene program and show that Klf5, Ikzf1,
and Stat3 play an important role in age-related in-
flammatory myeloid bias. We have therefore identi-
fied and isolated an LT-HSC subset that regulates
myeloid versus lymphoid balance under inflamma-
tory challenge and with age.INTRODUCTION
Long-term hematopoietic stem cells (LT-HSCs) encounter
continued stresses throughout life, yet maintain appropriate im-
mune cell output (Akunuru and Geiger, 2016; Denkinger et al.,
2015; Dykstra et al., 2011; Geiger et al., 2013; Morita et al.,
2010; Sawai et al., 2016; Yamamoto et al., 2018). These stresses
include replicative stress (Bernitz et al., 2016; Flach et al., 2014;
Wang et al., 2012) and acute and chronic infectious challenge2992 Cell Reports 25, 2992–3005, December 11, 2018 ª 2018 The A
This is an open access article under the CC BY license (http://creative(King and Goodell, 2011; Nagai et al., 2006). Physiologic aging
in both humans and mice leads to permanent changes in
LT-HSC function, such asmyeloid-biased hematopoietic output,
and poor response to infections (Akunuru andGeiger, 2016). This
is often accelerated in settings of chronic inflammation and,
when dysregulated, can lead to replicative exhaustion and
extramedullary hematopoiesis (Esplin et al., 2011; Mehta et al.,
2015).
Hematopoietic stem and progenitor cells (HSPCs) express
innate immune receptors (King and Goodell, 2011), such as
Toll-like receptors (TLRs), and respond to many inflammatory
mediators, including interferon gamma (IFN-g) (Baldridge et al.,
2010), macrophage colony-stimulating factor (M-CSF) (Mossa-
degh-Keller et al., 2013), and the Gram-negative bacterial
component lipopolysaccharide (LPS) (Nagai et al., 2006). In
response to acute LPS exposure, LT-HSCs increase prolifera-
tion, mobilize to the peripheral bloodstream (King and Goodell,
2011), and initiate emergency myelopoiesis to increase the sys-
tem’s output of innate immune cells (Haas et al., 2015). This
increased output may also be mediated by hematopoietic pro-
genitors, such as multipotent progenitors (MPPs) (Pietras et al.,
2015; Young et al., 2016), in part due to the direct secretion of cy-
tokines that drive myeloid differentiation (Zhao et al., 2014).
Several hypotheses have been proposed to explain the age-
related changes in LT-HSC function (Kovtonyuk et al., 2016).
First, cell-intrinsic changes within each aged LT-HSC may
make it inherently myeloid biased (Grover et al., 2016; Rossi
et al., 2005). Second, the LT-HSC population may comprise sub-
sets of myeloid- and lymphoid-biased cells, the composition of
which changes with age such that myeloid-biased LT-HSCs
are more prevalent within the aged LT-HSC population (Dykstra
et al., 2007; Gekas and Graf, 2013; Yamamoto et al., 2013). The
true nature of these age-related changes may in fact be a com-
bination of both of these hypotheses, so that with age there is a
growing subset of more intrinsically myeloid-biased LT-HSCs.
The transcriptional and functional states of LT-HSCs in steady
state and in response to inflammatory mediators may help
shed light on these questions, but are still poorly understood.uthor(s).
commons.org/licenses/by/4.0/).
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Figure 1. Aged Hematopoietic Stem Cells Exposed to Inflammatory Signals Demonstrate Increased Myeloid Output in a Cell-Intrinsic
Manner
(A) Schematic overview of the approach.
(B–E) Young and agedmice were exposed to a second dose of LPS 1month after the initial LPS challenge and the frequencies of (B) CD11b+, (C) Gr-1+, (D) CD3+,
and (E) CD19+ were observed for 9 weeks.
(F)–(I) LT-HSCs sorted from young and aged CD45.2 mice were stimulated with LPS and Pam3csk4 for 2 hr before competitive transplant into CD45.1 recipients.
Peripheral blood CD45.2 (F) CD11b+, (G) Gr-1+, (H) CD3+, and (I) CD19+ frequencies were measured by flow cytometry at 3months post-reconstitution (n = 11–12
per group).
Data represent at least two independent experiments and are presented as means ± SEMs. *p < 0.05, **p < 0.01, and ***p < 0.001. p values were corrected for
multiple hypothesis testing by Bonferroni’s multiple comparison test.A number of epigenomic and transcriptomic changes have been
observed during bulk and single-cell expression analyses of
young and aged LT-HSCs (Cabezas-Wallscheid et al., 2014;
Grover et al., 2016; Kowalczyk et al., 2015; Sanjuan-Pla et al.,
2013; Sun et al., 2014; Yu et al., 2016). However, it is unclear
how these changes lead to altered LT-HSC function, as seen
with age-related myeloid bias (Dykstra et al., 2011; Gekas and
Graf, 2013; Yamamoto et al., 2018). In particular, a previous
study using single-cell RNA sequencing (scRNA-seq) (Kowalc-
zyk et al., 2015) of steady-state, resting LT-HSCs has not identi-
fied a subpopulation structure. An understanding of how inflam-
matory mediators effect the response of LT-HSCs and how this
response changes with age may therefore help elucidate theunderlying mechanism of age-related myeloid bias. This may
further provide insight into age-related pathologies such as
improper immune responses to vaccines or infectious challenge
and the development of myeloid leukemia.
In this work, we investigate the acute inflammatory response
of mouse HSPCs in vitro and in vivo and how this response
may be altered with age (Figure 1A). We show that major HSPCs
subtypes respond transcriptionally to inflammatory stimuli and
that age-dependent inflammatory myeloid bias is intrinsic to
LT-HSCs, based on bone marrow transplant experiments. Using
scRNA-seq, we find that the LT-HSC compartment comprises at
least two subsets that become apparent upon stimulation. One
of these subsets has features that are consistent with myeloidCell Reports 25, 2992–3005, December 11, 2018 2993
bias (referred to as mLT-HSCs), with distinct cell-intrinsic re-
sponses to inflammatory stimulation. Themyeloid-biased subset
expresses high levels of the surface marker CD61, can be pro-
spectively isolated and lead to myeloid bias upon reconstitution,
and increases dramatically with age. We further identify putative
transcriptional regulators of mLT-HSCs and demonstrate the
role of these regulators in age-related myeloid bias and differen-
tial responses to TLR ligands.
RESULTS
Inflammation in Aged and Young Mice Leads to
Differential Increases in Myeloid Output
To investigate the acute inflammatory response of hematopoi-
etic progenitors from mice at different ages, we challenged
8- to 12-week-old (‘‘young’’) and 20- to 24-month-old
(‘‘aged’’) mice with a single intraperitoneal injection of LPS
(0.5 mg/kg; Figures S1A–S1D). We observed a >2-fold increase
in peripheral blood myeloid frequencies in aged mice by 72 hr
post-challenge, whereas only a minimal increase was seen in
young mice (Figures S1A and S1B). These changes in myeloid
output returned to baseline frequencies by 9 weeks post-chal-
lenge. The baseline frequency of T cells in aged mice was
2-fold lower than in young mice, but both cohorts had
increased T cell output 72 hr after LPS challenge (Figure S1C).
In contrast, B cell output in both young and aged cohorts
decreased after LPS treatment, and the acute response was
particularly dramatic in aged mice, which had a 2-fold loss in
the frequency of B cells by 72 hr and then recovered to baseline
levels by 6 weeks post-challenge (Figure S1D). Aged mice
therefore demonstrated a strong acute increase in myeloid
output in response to inflammatory challenge that was not
observed in young mice.
To evaluate the cumulative effect of acute inflammatory chal-
lenges on myeloid output, we performed a second LPS injection
in all cohorts 1 month after the initial challenge. This resulted in
an upregulation of peripheral blood myeloid cells in aged mice,
whereas again, only a milder increase in myeloid output was
seen in young mice (Figures 1B and 1C). While myeloid output
in young mice returned to baseline within 3 weeks, the myeloid
cell frequencies of aged mice mildly decreased 3 weeks post-in-
jection, but remained higher than baseline for at least 9 weeks
post-injection (Figures 1B and 1C). T cell levels slightly increased
in young mice by 72 hr and did not change in aged mice (Fig-
ure 1D). Conversely, B cell output decreased in both aged and
youngmice by 72 hr, but while young B cells returned to baseline
levels, the B cell levels of aged mice remained lower than base-
line by 9 weeks post-injection (Figure 1E).
The spleens of stimulated aged mice revealed increased
myeloid cell frequencies and a dramatic loss of T cells compared
to young mice (Figure S1E). Finally, the bone marrow of stimu-
lated aged mice had a 3-fold enrichment for LT-HSCs compared
to stimulated youngmice, with a milder enrichment in short-term
HSCs (ST-HSCs) and MPPs (Figure S1F). This enrichment in
LT-HSCs is higher than the 2-fold enrichment reported between
unstimulated aged and youngmice (Beerman et al., 2010; Mehta
et al., 2015). These results suggest that repeated acute inflam-
matory stimuli in aged mice enhance myeloid-biased output2994 Cell Reports 25, 2992–3005, December 11, 2018from HSPCs and that the differences in immune cell output
may originate from LT-HSCs.
Inflammation Leads to a Distinctive, Long-Term
Myeloid-Biased Output in Aged LT-HSCs
To examine whether inflammation leads to a cell-intrinsic
myeloid bias in LT-HSCs, we tested the impact of stimulation
on the ability of young and aged LT-HSCs to reconstitute the im-
mune system. Specifically, we first sorted LT-HSCs, ST-HSCs,
and MPPs from young and aged CD45.2 C57BL/6 mice. The
sorted cells were either maintained unstimulated or stimulated
with LPS and Pam3csk4 for 2 hr in vitro and subsequently trans-
planted into lethally irradiated young CD45.1 C57BL/6 mice.
Peripheral blood counts of CD45.2-expressing cells were moni-
tored for 4 months (Figures 1F–1I, S2A, and S2B). Both unstimu-
lated and stimulated young and aged LT-HSCs demonstrated
long-term reconstitution of the immune system in primary and
secondary transplanted mice (Figures S2A–S2D).
At 3 months post-reconstitution (i.e., 3 months after the in vitro
LPS and Pam3csk4 challenge), inflammatory challenge of young
LT-HSCs did not lead to altered peripheral blood myeloid and
lymphoid cell frequencies compared to unstimulated controls
(Figures 1F–1I). As previously reported (Beerman et al., 2010;
Pang et al., 2011), unstimulated aged LT-HSCs had higher pe-
ripheral blood myeloid output and lower lymphoid output
compared to unstimulated young LT-HSCs (Figures 1F–1I).
However, stimulated aged LT-HSCs demonstrated a marked
additional increase in the frequency of peripheral blood myeloid
cells (Figures 1F and 1G) and a further decrease in the frequency
of peripheral blood B cells (Figure 1H). Thus, aged LT-HSCs
demonstrated myeloid-biased ‘‘memory’’ of the initial in vitro
LPS and Pam3csk4 challenge that persisted for several months
post-reconstitution, a phenomenon not seen with stimulated
young LT-HSCs. No significant difference in LT-HSC frequency
was observed between cohorts, including in the previously iden-
tified myeloid-biased CD41+ LT-HSC subpopulation (Gekas and
Graf, 2013) (Figures S2E–S2H). These results suggest that direct
TLR stimulation of aged LT-HSCs leads to a long-term increase
in myeloid bias. It is not clear, however, whether this increase is
cell intrinsic or due to changes in the composition of the LT-HSC
population.
HSPCs Demonstrate a Canonical Transcriptional
Response to TLR Ligands
We hypothesized that the differential effects of young and aged
stimulated LT-HSCs may be due to a variable transcriptional
response to inflammatory signals. To test this hypothesis, we
measured the transcriptional profiles of populations of HSPCs
from young and aged mice during a 12-hour time course of
LPS and Pam3csk4 stimulation in vitro (Figure 2A). LT-HSCs,
ST-HSCs, and MPPs from both young and aged mice demon-
strated a robust and similar transcriptional response to inflam-
matory stimuli (Figure 2B; Table S1), which largely resembled
that seen in mature cell types with different physiological func-
tions such as bonemarrow-derived dendritic cells (BMDCs) after
LPS stimulation (Figures 2B–2D) (Jovanovic et al., 2015). This
response includes the same temporal ordering of induction in in-
flammatory gene clusters as in mature cell types (Amit et al.,
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Figure 2. Early Hematopoietic Progenitors Demonstrate a Rapid Transcriptional Response to Inflammatory Signals
(A) Schematic of LPS and Pam3CSK4 time course experiment. LT-HSCs, ST-HSCs, and MPPs from five young and five aged mice were exposed to LPS and
Pam3CSK4 in vitro for the indicated time, after which RNA was harvested for bulk RNA sequencing.
(B) Heatmap of differentially expressed genes in young and aged hematopoietic progenitors alongside an expression map of mature bone marrow-derived
dendritic cells (DCs) challenged with LPS for comparison.
(C) Heatmap of NF-kB-regulated inflammatory genes clustered by temporal expression patterns described previously.
(D) Heatmap of cytokines expressed in early progenitors and DCs.2009; Ramirez-Carrozzi et al., 2009), upregulation of nuclear fac-
tor kB (NF-kB)-related genes (Figure 2C) (Bhatt et al., 2012; Hao
and Baltimore, 2009), and induction of the expression of several
effector cytokines (Figure 2D), albeit at slightly lower levels (Fig-
ures S3A–S3C). Among the differentially expressed genes be-
tween all of the cell types, HSPCs from both young and aged
mice presented similar patterns compared to BMDCs (Figure 2B;
for a complete list of differentially expressed genes and their
Gene Ontology [GO] enrichments, see Table S2). Thus, the
response of young and aged HSPCs to inflammatory activation
resembles the canonical response of mature cells to similar stim-
ulation, both in the identity of the regulated genes and in thetimescale of the response. This suggests that the differences in
the reconstitution outcome were not simply related to the differ-
ences in the transcriptional responsewhenmeasured at the pop-
ulation level.
scRNA-seq Reveals Two Subsets of LT-HSCs with
Distinct Responses to Inflammatory Stimulus
Next, we considered the possibility that there are different sub-
sets of LT-HSCs either in steady state or post-stimulation
(‘‘cell-intrinsic changes’’) and that their relative proportions
may change with age (‘‘compositional changes’’). Early he-
matopoietic progenitors comprise heterogeneous functionalCell Reports 25, 2992–3005, December 11, 2018 2995
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subpopulations (Benz et al., 2012; Gekas and Graf, 2013; Mor-
ita et al., 2010; Sanjuan-Pla et al., 2013), which often reveal
themselves in response to inflammatory stimuli (Haas et al.,
2015; Zhao et al., 2014). While a previous scRNA-seq study
we performed of LT-HSCs has mostly revealed age-related
differences in the cell cycle (Kowalczyk et al., 2015), we hy-
pothesized that stimulation could unveil additional cell-intrinsic
distinctions that were not observed in resting cells.
To determine the composition of HSPCs in each age group
and condition, we performed full-length scRNA-seq (Picelli
et al., 2013) of young and aged LT-HSCs, ST-HSCs, and
MPPs, with and without 2 hr of in vitro LPS and Pam3csk4 stim-
ulation of sorted cells. As we aimed to distinguish cell-intrinsic,
possibly subtle, stimulus-specific states within a very-well-
defined cell population, we opted for the deeper coverage full-
length scRNA-seq approach over massively parallel approaches
(Tanay and Regev, 2017; Wagner et al., 2016). We profiled 2,046
individual cells from 9mice (5 young, 4 aged), with 124–186 cells
for each given cell type and condition. To eliminate sources
of variability resulting from known confounding factors, we
removed 611 cells as being of low quality and 58 as possible
contaminants (STAR Methods). In addition, 578 of the cells
were actively cycling (STAR Methods). Overall, we retained 949
cells for subsequent analysis, comprising 187 MPPs, 404 ST-
HSCs, and 358 LT-HSCs.
We identified 3 major groups of cells using unsupervised
clustering (STAR Methods), denoted clusters 1, 2, and 3 (Fig-
ure 3A). Cluster 1 (311 cells) contained most (302 of 354) of
the unstimulated HSPCs of all types, forming a continuum
from MPPs to LT-HSCs (Figure 3B), with aged and young
LT-HSCs clustering together (Figure 3D), and hardly any stim-
ulated cells. Clusters 2 (103 cells) and 3 (421 cells) almost
exclusively contained stimulated HSPCs (Figure 3C) and had
opposing patterns with respect to aged and young LT-HSCs
(Figure 3E): cluster 3 contained 77% of the aged stimulated
LT-HSCs and only 13% of the young stimulated LT-HSCs,
whereas cluster 2 had 72% of the young stimulated LT-HSCs
and only 10% of the aged stimulated LT-HSCs (Figure 3E).
This suggests that there are distinct subsets of LT-HSCs in
the bone marrow that can be discerned by their different
cell-intrinsic responses to stimulation and that the relative fre-
quencies of these subsets appear to change with age. Of note,
the distinction between these LT-HSC subsets could be dis-
cerned only with stimulation, and no significant difference
was found within unstimulated or stimulated ST-HSCs or
MPPs (Figures S3D and S3E). Given these findings, we
focused further analyses on LT-HSCs.(B–E) Single-cell t-SNE plots (as before) indicating all cell types among (B) unstimu
stimulated LT-HSCs.
(F) Correlation across cells between DE genes common to both simulated cluster 3
of correlated genes are identified.
(G) Heatmap represents the expression values of genes in the unstimulated myel
bottom show the myeloid signature score for each cell and is the basis for the or
from which the cells were derived.
(H) Enrichment of transcription factor motifs in enhancers of cluster 3- versus clu
differential expression of the transcription factor (TF) genes themselves in the
enrichment score >0.5 indicates that the TF motif is enriched among genes that a
expressed more highly in cluster 2.Myeloid-Biased LT-HSCs Can Be Identified by a Distinct
Gene Signature under Inflammatory Conditions
To identify the differences between stimulated LT-HSCs in clus-
ter 3 and cluster 2, we examined genes that were differentially
expressed between the two clusters. Cluster 3-specific genes
were enriched for genes related to myeloid function and inhibit-
ing lymphoid differentiation, including pathways related to
NF-kB localization, negative regulation of lymphocyte develop-
ment, macrophage proliferation, cell migration and localization,
and platelet-derived growth factor signaling (Figure S3F). Cluster
2-specific genes were enriched for genes involved in lympho-
cyte development, cell proliferation, and acute inflammatory
response (Figure S3G). Cells in any given cluster, regardless of
age, were similar to one another and distinctly different from cells
in the other cluster. These data are consistent with a model in
which aged and young LT-HSCs have different proportions of
cells that display unique lineage-biased pathway preferences
in response to inflammatory signals.
To test whether the LT-HSC subsets also exist in unstimulated
cells in steady-state conditions, we identified 47 genes that were
significantly differentially expressed both when comparing clus-
ter 3 versus cluster 2 (single-cell differential expression [SCDE]
[Kharchenko et al., 2014], false discovery rate [FDR] <0.01) and
when comparing unstimulated aged versus young LT-HSCs
within cluster 1 (Figure S3H; STAR Methods; SCDE FDR <0.1).
We then tested whether these 47 genes coherently co-vary
across the 149 unstimulated LT-HSCs, and thus may reflect a
variable cell state within these cells. We identified three distinct
co-varying gene clusters (Figure 3F), two of which contained
genes involved in myeloid and platelet differentiation, including
Selp, Vwf, Gpr64, Plscr2, and Wdfy1. Notably, recent studies
have reported myeloid-biased CD41, Vwf, or CD150-high ex-
pressing LT-HSC subpopulations (Dykstra et al., 2011; Gekas
and Graf, 2013; Sanjuan-Pla et al., 2013); in our analysis, aged
LT-HSCs have increased yet variable expression of CD150 and
Vwf and no significant difference in CD41 expression (Figures
S3I–S3K).
Next, we generated a refined gene signature. We first scored
unstimulated LT-HSCs with the initial set of 47 genes (Fig-
ure S3H), identifying 2 putative cell subsets (STAR Methods).
Second, we used these subsets to initialize k-means clustering
(k = 2) within the unstimulated LT-HSCs. We used the identities
of the cells based on this clustering to designate them as
myeloid-biased LT-HSCs (mLT-HSCs) and non-mLT-HSCs
(nmLT-HSCs). We tested these 2 final clusters for differentially
expressed genes, finding 365 upregulated genes and 34 down-
regulated genes in the mLT-HSC cluster, which we used tolated and (C) stimulated cells, andmouse ages among (D) unstimulated and (E)
versus cluster 2 and unstimulated aged versus young LT-HSCs. Three clusters
oid-biased gene signature for each single unstimulated LT-HSC. The panels at
dering of the x axis. The bottom color-coded bar shows the age of the animals
ster 2-specific genes for all cells (left), or only aged LT-HSCs (right) (x axis) and
same comparison (y axis). Significant genes (FDR <0.1) are indicated. An
re expressed more highly in cluster 3, while a score <0.5 indicates that the TF is
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define ourmLT-HSC signature (SCDE FDR<0.1 and the same di-
rection of change as for stimulated mLT-HSCs) (Table S3).
In the final k-means clusters, 92% of cells in the myeloid-
biased cluster were aged cells and only 8% were young cells
(Figure 3G, right of the dashed line), while only 20% of cells in
the non-myeloid-biased cluster were aged cells and 80% were
young cells (Figure 3G, left of the dashed line). This is consistent
with our finding that the frequency of stimulated mLT-HSCs in-
creases with age (Figure 3E). Applying the same signature to
our stimulated LT-HSCs or to an independent dataset of unsti-
mulated aged and young LT-HSCs from two mouse strains
(Kowalczyk et al., 2015) showed consistent results; while the
LT-HSC population is inherently heterogeneous, more aged
LT-HSCs score highly for the mLT-HSC signature (Figures S3L
and S3M). Thus, the mLT-HSC signature allowed us to identify
the subtle portion of myeloid-biased-like cells among the young
unstimulated LT-HSCs and to show that the proportion of high-
scoring mLT-HSC cells increases with age.
Klf5, Ikzf1, and Stat3 Regulate Age-Related
Inflammatory Myeloid Bias of LT-HSCs
To identify transcription factors (TFs) that may regulate differen-
tially expressed genes between the mLT-HSC and nmLT-HSC
subsets, we looked for enriched TF motifs in the enhancer se-
quences associated with these genes (Lara-Astiaso et al.,
2014) (Figure 3H). In particular, we focused on TFs that them-
selves were differentially expressed between mLT-HSCs and
nmLT-HSCs, because altered transcriptional regulation of a TF
may affect its target genes. Among the nine significant TFs
whose motifs were enriched in enhancers of differentially ex-
pressed genes were HoxA9, Klf4, Klf5, Ikzf1, and Stat3, which
we chose to further test given their known putative roles in
HSPC biology (Figure 3H, blue dots).
To test the role of these TFs in age-related myeloid bias, we
transplanted young or aged HSPCs with short hairpin RNA
(shRNA) knockdowns of each TF into young irradiated C57BL/6
recipient mice (Figure S4A). Of the tested TFs in steady state,
Klf5, Ikzf1, and Stat3 had significant, age-dependent effects,
whereas HoxA9 and Klf4 did not (Figures S4B–S4E). Consistent
with the upregulated expression of Klf5 in mLT-HSCs, we found
that knock down of Klf5 in aged LT-HSCs resulted in increased
lymphoid output (Figure S4C) and decreased myeloid output
to levels seen with control young LT-HSCs (Figures S4D and
S4E). There was no immediately apparent effect of Klf5 knock-
down in young LT-HSCs. Knock down of Ikzf1 in young LT-
HSCs resulted in decreased lymphoid output (Figure S4C).
Knockdown of Ikzf1 in aged LT-HSCs had no significant effect
on lymphoid output, but like knock down of Klf5, it resulted in
decreased myeloid output to levels seen with control young
LT-HSCs (Figures S4D and S4E).
We next tested whether these TFs regulate the myeloid output
of LT-HSCs under conditions of inflammatory stress. To do this,
we challenged the aforementioned shRNA knockdownmicewith
LPS (as in Figures 1B–1E). As expected, after the LPS challenge,
mice transplanted with control aged LT-HSCs showed a sus-
tained upregulation of myeloid output during the 3 weeks (Fig-
ures 4A–4C, solid red lines), whereas mice transplanted with
control young HSPCs had only a transient increase in myeloid2998 Cell Reports 25, 2992–3005, December 11, 2018output, followed by rapid recovery to baseline (Figures 4A–4C,
solid black lines). The response to LPS of mice transplanted
with aged HSPCs expressing Klf5, Ikzf1, or Stat3 shRNAs phe-
nocopied that of mice transplanted with control young HSPCs
(Figures 4A–4C and S4F–S4H, dashed red lines). Thus, Klf5,
Ikzf1, and Stat3may play a critical role in regulating inflammatory
myeloid bias in aged LT-HSCs. No dysregulation in immune
output was seen in mice transplanted with HSPCs expressing
HoxA9, Klf4, or Zbtb4 shRNAs (data not shown).
To identify the cell types that are responsible for the changes
observed after Ikzf1, Stat3, or Klf5 knockdown in aged HSPCs,
we analyzed the bone marrow compartment of all of the mice
3 months post-transplantation. Mice transplanted with aged
control cells had higher LT-HSC and common myeloid progeni-
tor (CMP) frequencies and lower common lymphoid progenitor
(CLP) frequencies, but no changes in other early progenitor pop-
ulations when compared to mice reconstituted with young con-
trol cells (Figures 4D–4F and S4I–S4K). Knock down of either
Klf5, Ikzf1, or Stat3 in transplanted aged HSPCs resulted in a
decreased frequency of LT-HSCs compared to control aged
HSPCs (Figure 4D). We observed no significant effect on the fre-
quency of LT-HSC in the bone marrow in mice transplanted with
young HSPCs expressing any of these knockdown constructs
(Figure 4D, gray bars) or in aged HSPC transplanted mice ex-
pressing HoxA9 or Klf4 shRNAs (data not shown). These data
therefore suggest that Klf5, Ikzf1, and Stat3may regulate inflam-
matory myeloid bias in aged LT-HSCs and may do so by altering
the function and frequency of LT-HSCs in the bone marrow
compartment.
To investigate whether the expression of Ikzf1, Stat3, and
Klf5 is sufficient to skew the LT-HSC output, we overexpressed
these genes in young and aged HSPCs and transplanted these
cells into young irradiated C57BL/6 mice (STAR Methods).
Ikzf1 and Klf5 overexpression (OE) led to an increase in
myeloid output and a decrease in lymphoid output at 3 months
post-reconstitution with both young and aged HSPC donor
cells (Figures 4G–4I and S5A–S5C). A significant increase in
myeloid output was observed after a single LPS injection in
Ikzf1 and Klf5 OE mice compared to age-appropriate controls.
Conversely, Stat3 OE in both young and aged donor HSPCs
yielded comparable myeloid output, which resembled that of
aged control mice following LPS injection (Figures 4G–4I
and S5A–S5C, dashed lines). Analysis of the bone marrow
compartment of Klf5 OE mice revealed a marked increase in
the frequency of LT-HSCs, but no differences in the frequency
of ST-HSCs or MPPs. Klf5 OE did affect downstream progen-
itors, yielding a higher frequency of bone marrow CMPs and
granulocyte macrophage progenitors (GMPs), and a decrease
in the frequency of CLPs in both young and aged donors
compared to age-matched controls (Figures 4J–4L and S5D–
S5H). Similarly, Ikzf1 OE in both young and aged mice resulted
in an increase in bone marrow LT-HSC frequency and a
decrease in CLP and lymphoid-primed multipotent progenitor
(LMPP) frequencies. Stat3 OE did not significantly alter LT-
HSC frequencies in young or aged mice (Figures 4J–4L and
S5D–S5H). These data therefore suggest that Klf5, Ikzf1, and
Stat3 may be necessary and sufficient to promote inflamma-
tory myeloid bias.
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Figure 4. Klf5, Ikzf1, and Stat3 Regulate Steady-State and Inflammatory Age-Related Myeloid Bias
Bonemarrow cells from young and agedC57BL/6micewere transducedwith constructs to either knock down (denoted SH in A–F) or overexpress (denoted OE in
G–L) the indicated transcription factors. These cells were subsequently reconstituted into lethally irradiated young C57BL/6 recipient mice. These mice were
subsequently challenged with a single sublethal dose of LPS, and peripheral blood immune cells were tracked over time by flow cytometry. Shown are peripheral
blood myeloid cells for mice with knock down or overexpression of (A) and (G) Ikzf1, (B) and (H) Klf5, and (C) and (I) Stat3. These mice were subsequently
harvested, and the bone marrow was analyzed for the frequency of (D) and (J) LT-HSCs, (E) and (K) CMPs, and (F) and (L) CLPs from knockdown and over-
expression mice, respectively.
Data represent at least two independent experiments (n = 8–10mice per group) and are presented asmeans ± SEMs. In (A)–(C), (G), and (H),^denotes p < 0.05 for
aged shRNA or OE versus agedMG, v denotes p < 0.05 for aged shRNA or OE versus youngMG using two-way ANOVA. In (D)–(F) and (J)–(L), *p < 0.05, **p < 0.01,
and ***p < 0.001. p values were corrected for multiple hypothesis testing by Bonferroni’s method.
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Figure 5. CD61 Expression on LT-HSCs Is a Marker for mLT-HSCs
(A) Flow cytometry plots showing CD61 expression in aged and young LT-HSCs.
(B–E) Total LT-HSCs and those with elevated (CD61-high) and decreased (CD61-low) expression of CD61 from aged and young mice were transplanted into
lethally irradiated young C57BL/6 recipient mice. Mice were subsequently challenged with a single dose of LPS, as in Figure 1. Shown are the peripheral blood
CD11b+ cell frequencies frommice transplanted with (B) young and (C) aged donor LT-HSCs, and the peripheral blood Gr-1+ frequencies frommice transplanted
with (D) young and (E) aged donor LT-HSCs.
(F–K) Transplanted micewere harvested at 4months post-reconstitution. Shown are the bonemarrow frequencies of (F) LT-HSCs, (G) CD61+ LT-HSCs, (H) CLPs,
(I) GMPs, (J) CMPs, and (K) MEPs in these mice.
(legend continued on next page)
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CD61 Is a Marker for mLT-HSCs
To identify putative surface markers that may characterize mLT-
HSCs, we searched the set of genes that were differentially
expressed between mLT-HSCs and nmLT-HSCs for those en-
coding surface proteins that also have a commercially available
antibody (Figure S6A; Table S4). Among the surface proteins
whose gene expression was elevated in mLT-HSCs compared
to nmLT-HSCs were CD61 (Itgb3), CD62p, CD166, CD38, and
CD34 (Figure S6A). We tested the surface expression of five of
these proteins in aged and young LT-HSCs using flow cytometry
(Figures 5A and S6B) and identified CD61 as the most differen-
tially expressed surface protein between the two populations
(Figure 5A). The relative proportion of high CD61 expressing
LT-HSCs (CD61-high LT-HSCs) and low CD61 expressing LT-
HSCs (CD61-low LT-HSCs) was consistent with the proportions
of mLT-HSCs and nmLT-HSCs, respectively, as identified in
aged and young mice (Figures S6C and S6D). CD61 encodes
for b3 integrin. In hematopoietic cells, CD61 has been shown
to heterodimerize with aV/CD51, a5/CD49e, and aIIB/CD41 to
form aVb3, a5b3, or the platelet-specific aIIBb3integrins, respec-
tively (Nemeth et al., 2007; Shattil et al., 1998). Using flow
cytometry, we found that on LT-HSCs CD51 expression levels
correlate most to that of CD61, while CD49e and CD41 expres-
sion was only partially correlated with CD61 (Figures S2F, S2H,
and S6E–S6G).
We next tested whether CD61-high LT-HSCs are functionally
myeloid biased. We sorted CD45.2 CD61-high and CD61-low
LT-HSCs (Figures S6C and S6D) from both young and aged
mice and transplanted them into young lethally irradiated
CD45.1 C57BL/6 mice. At 3 months post-reconstitution, the pe-
ripheral blood from mice transplanted with either young or aged
CD61-high LT-HSCs had decreased T cell and B cell output and
increased myeloid and granulocyte output (Figures S7A–S7D),
compared to mice transplanted with young CD61-low cells. To
test whether CD61-high LT-HSCs are more prone to inflamma-
tory myeloid bias, we challenged these transplanted mice with
LPS. Mice transplanted with both young and aged CD61-high
LT-HSCs had a more pronounced and sustained increase in pe-
ripheral blood myeloid and a decrease in lymphoid output
3 weeks post-challenge when compared to mice transplanted
with total LT-HSCs and CD61-low LT-HSCs of comparable
age (Figures 5B–5E and S7E–S7H).
To investigate the cellular basis of myeloid bias with the
transplant of CD61-high LT-HSCs, we harvested bone marrow
from all of the transplanted mice and analyzed for early he-
matopoietic progenitors. The bone marrow of mice that had
received CD61-high LT-HSCs, whether young or aged, had
increased frequencies of LT-HSCs (Figure 5F), the majority of
which were CD61-high LT-HSCs compared to mice trans-
planted with CD61-low LT-HSCs (Figure 5G; 56% and 74%
of total LT-HSCs in mice transplanted with young and aged
CD61-high LT-HSCs, respectively). The frequency of CD61-
high LT-HSCs in mice transplanted with either young or aged(A) CD61-high frequencies and SD are depicted for aged (red) and young (blue)
(B–K) Data represent at least two independent experiments (n = 7–12 per group)
control, v denotes p < 0.05 for CD61-low versus control using two-way ANOVA
hypothesis testing by Bonferroni’s method.CD61-low LT-HSCs was similar to that in mice transplanted
with total LT-HSCs of young mice, and >3-fold lower than
that of mice transplanted with CD61-high LT-HSCs or total
aged LT-HSC mice (Figure 5G). This suggests that CD61-low
LT-HSCs may have the potential to convert to a CD61-high
LT-HSC phenotype. Consistent with their myeloid-biased
phenotype, mice transplanted with CD61-high LT-HSCs had
decreased bone marrow CLPs (Figure 5H) and increased
GMPs, CMPs, and megakaryocyte-erythrocyte progenitors
(MEPs) (Figures 5I–5K) compared to mice transplanted with
CD61-low LT-HSCs, regardless of age.
DISCUSSION
In this work, we demonstrate that LT-HSCs have a heteroge-
neous response to inflammatory stimuli that is altered with
age. We show that even the most multipotent of HSPCs directly
respond in vitro to TLR ligands with a potent transcriptional
response. Using scRNA-seq, we demonstrate that both the
young and aged LT-HSC compartments comprise at least two
distinct subsets of cells with a defined molecular signature. We
identify CD61 as a marker of inflammation-responsive mLT-
HSCs. We posit that an increased proportion of mLT-HSCs in
the bonemarrow is a key driver of myelopoiesis and further iden-
tify several TFs that regulate steady state and inflammatory
myeloid bias in aged LT-HSCs. Our data suggest a revised
model (Figure 6) of how inflammation affects LT-HSC function
and composition with age.
We show that various types of HPSCs respond transcription-
ally to TLR ligands in vitro in a similar way to that seen in BMDCs
after LPS stimulation (Ramirez-Carrozzi et al., 2009). Given the
different functional roles of HSPCs and mature immune cells,
this similarity in transcriptional response is surprising. It has
been suggested that, as in mature cell types, inducing the
expression of NF-kB with LPS and Pam3csk4 in HSPCs may
affect cytokine secretion and proliferation (Zhao et al., 2011,
2014). We observed that the dynamics of expression of NF-kB-
driven genes was largely similar between HSPCs and BMDCs.
Thus, the majority of NF-kB-responsive genes appears to be
regulated similarly in both HSPCs and mature cells.
While it has been demonstrated that TLR stimulation of LT-
HSCs induces their proliferation (Zhao et al., 2013), our results
suggest that it does not alter their long-term reconstitution
potential. Aged LT-HSCs maintained a memory of the in vitro
inflammatory challenge and had increased myeloid output
3 months after transplant compared to unstimulated aged LT-
HSCs. These data therefore confirm that LT-HSCs directly sense
TLR ligands (Nagai et al., 2006), and in response to this, the aged
LT-HSC population has an amplified cell-intrinsic myeloid bias.
In the context of physiologic aging, it may be that the accumula-
tion of inflammatory challenges during the lifetime of an animal
results in selection and expansion of mLT-HSCs, partially due
to direct sensing of these inflammatory signals by these cells.(n = 4 per group).
and are presented as means ± SEMs.^denotes p < 0.05 for CD61-high versus
. *p < 0.05, **p < 0.01, and ***p < 0.001. p values were corrected for multiple
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Figure 6. Model of LT-HSC Aging and Inflam-
matory Myeloid Bias
Shifts in clonal heterogeneity during LT-HSC aging
affects the inflammatory response of LT-HSCs.
The LT-HSC compartment comprises unbiased and
myeloid-biased LT-HSCs. With age, the clonal dis-
tribution of LT-HSCs shifts toward myeloid-biased
variants, which express high levels of CD61. During
acute inflammatory challenges, aged myeloid-
biased LT-HSCs preferentially expand, leading to
increased myeloid output. Several cell-intrinsic fac-
tors, including the transcriptional regulators Klf5,
Ikzf1, and Stat3, may play a role in establishing a
myeloid-biased differentiation program during aging
and inflammation. Extrinsic factors, including in-
flammatory cytokines and growth factors secreted
from other cell types, may also play a role.mLT-HSC enrichment in turn leads to myeloid bias, further
amplifying chronic inflammation and forming a positive feedback
loop generating the expansion of mLT-HSCs. This hypothesis is
supported by the fact that chronic inflammatory stimulation of
young mice, either by repeated LPS challenge or another form
of NF-kkB activation, leads to myeloid-biased output (Esplin
et al., 2011; Zhao et al., 2013). In addition, human chronic inflam-
matory diseases such as rheumatoid arthritis in relatively young
individuals present with functional changes in HSPCs and a
myeloid bias, mirroring aged individuals (Wunder and Henon,
2012; Colmegna et al., 2008). Given that the LT-HSC population
is heterogeneous, it has yet to be determined whether inflamma-
tion plays a role in either expanding the number of cells in the
mLT-HSC state or changing the state of nmLT-HSCs to an
mLT-HSC-like state over time.
Using scRNA-seq, we identified subsets within the LT-HSCs
population, with distinct transcriptional responses to inflamma-
tory signals. Previous efforts have identified phenotypic markers
for megakaryocyte- and mLT-HSC subpopulations (Dykstra
et al., 2011; Gekas and Graf, 2013). The gene signature in this
study provides functional insight into the basis of myeloid bias
in the context of aging and inflammation. Using this gene signa-
ture from stimulated LT-HSCs, we uncovered a subset of mLT-
HSC-like cells enriched in the unstimulated aged LT-HSC
compartment that have the potential to respond uniquely to
acute inflammatory signals. This is consistent with recent results
suggesting that there is an epigenetically primed subset of LT-
HSCs that is uniquely poised to respond to LPS (Yu et al.,
2016). We show here that such a subset may also be identified
using mRNA expression data.
We identified CD61 as a functional surface marker for mLT-
HSCs. CD61-high LT-HSCs from both young and aged mice led3002 Cell Reports 25, 2992–3005, December 11, 2018to myeloid bias in transplantation experi-
ments, confirming it as aphenotypicmarker
for mLT-HSCs. CD61 is the b3 integrin sub-
unit, which dimerizes with ItgaV (CD51) to
form the vitronectin receptor Itgb3aV, pre-
dominantly expressed on macrophages,
osteoclasts, dendritic cells, and platelets.
CD61 expression has been shown tocontribute to the repopulating efficiency of LT-HSC (Umemoto
et al., 2008), quiescence (Umemoto et al., 2006), and proliferation
(Khurana et al., 2016). Consistent with this, we see that reconsti-
tution efficiency inCD61-lowLT-HSCs fromboth youngandaged
mice is hampered compared to CD61-high and total LT-HSCs
(Figure S7I). Our transplantation experiments with purified
CD61-low and CD61-high LT-HSCs resulted in a distribution of
CD61 expression in LT-HSCs resembling young and aged total
LT-HSC transplants, respectively. This suggests that there may
be plasticity betweenmLT-HSC and nmLT-HSC subpopulations,
and it supports the hypothesis that the composition of intrinsically
mLT-HSCs changes with age. While we show that CD61 can be
used as a phenotypic marker, whether it has a functional role in
the formation of mLT-HSCs has yet to be determined.
Weadditionally identifiedseveral transcriptional regulatorsof in-
flammatory myelopoiesis in aged stimulated mLT-HSCs. Among
these was Klf5, which is required for embryonic stem cell self-
renewal (Jiang et al., 2008). The enrichment of Klf5 in mLT-HSCs
may therefore play a role in the increased symmetric self-renewal
divisions seen in aged LT-HSCs (Geiger et al., 2013; Sudo et al.,
2000). Knock down of Klf5in aged LT-HSCs, but not in young
LT-HSCs, results in decreased myeloid output and decreased
LT-HSC bone marrow frequency, while overexpression leads to
the opposite effect. Consistent with these results, it has recently
been shown that deficiencyofKlf5 in LT-HSCs leads todecreased
bonemarrow homing of these cells in transplant experiments and
reduced output of myeloid cells, especially neutrophils (Shahrin
et al., 2016; Taniguchi Ishikawa et al., 2013).
The role of Ikzf1 in LT-HSC function is less well understood.
Previous studies have suggested that Ikzf1 does not play a role
in themyeloid versus the lymphoid lineage commitment of young
LT-HSCs (Ng et al., 2009). Our results suggest that in the context
of inflammation, Ikzf1may indeed have a positive role in myeloid
fate decisions. We found that any perturbation of Ikzf1 expres-
sion levels affects the differentiation potential of LT-HSCs.
Consistent with this, Ikzf1 has been shown to bind enhancer el-
ements of both myeloid and lymphoid genes in human HSPCs
(Novershtern et al., 2011). Knock down of Stat3 in aged LT-
HSCs also severely hamperedmyeloid output after inflammatory
challenge. This is consistent with the role of Stat3 as a major in-
flammatory TF. In particular, some studies suggest that Stat3 is
induced in response to TLR4 signaling in certain cell types (Kor-
tylewski et al., 2009). Complete knock out of Stat3 in LT-HSCs
has been shown to result in a premature aging phenotype
(Mantel et al., 2012); our results suggest that partial loss of
Stat3 is not enough to recapitulate this phenotype.
In summary, our analysis has uncoveredmLT-HSCs; identified
CD61, a previously unreported marker for inflammation-respon-
sivemLT-HSCs; and revealed three TFs—Klf5, Ikzf1, andStat3—
as important regulators of inflammatory myeloid bias. Since
altering the expression of these TFs can alter the balance of
myeloid and lymphoid cells during emergency myelopoiesis,
manipulating them or other aspects of the unstimulated or stim-
ulated mLT-HSC programs may provide new therapeutic ave-
nues for re-establishing appropriate lymphoid versus myeloid
balance to improve immune function and prevent myeloid leuke-
mias with age.STAR+METHODS
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qScript cDNA SuperMix Quanta 95048-100
KAPA HiFi HotStart ReadyMix KAPA biosystems KM2602
Deposited Data
RNA-Seq Gene Expression and IR Data This Paper GEO: GSE100428
Experimental Models: Cell Lines
HEK293T ATCC CRL-3216
Experimental Models: Organisms/Strains
Mouse: C57BL/6J Jackson Laboratory 000664
Mouse: C57BL/6J Charles Rivers Laboratories C57BL/6NCrl
Oligonucleotides - source
Primers used Table S5 This paper
shRNA sequences Table S5 This paper
cDNA sequences for TFs overexpression Table S5 This paperCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Mati
Mann (mati@caltech.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
The California Institute of Technology Institutional Animal Care and Use Committee approved all experiments. Young and aged
C57BL/6WTmales and femalesmicewere obtained fromCharles Rivers Laboratories and housed in the CaltechOffice of Laboratory
Animal Resources (OLAR) facility. For all experiments, young mice were between 8-12 weeks of age and aged mice were between
20-24 months of age.Cell Reports 25, 2992–3005.e1–e5, December 11, 2018 e2
METHOD DETAILS
Flow cytometry
Tissues were first harvested and cells were homogenized. Samples were depleted of RBCs using RBC lysis buffer (BioLegend). Cells
were subsequently stained with fluorescently labeled antibody. Respective cell types were analyzed according to relevant surface
markers by using the following antibodies: CD45.1 and CD45.2, lineage-specific markers (CD11b, Gr-1, CD19, B220, CD3e,
Nk1.1 and Ter119), or progenitor-specific markers (CD150, CD48, Flt3, CD34, FcRgamma and IL7R). All antibodies were purchased
from BioLegend. HSPCs were sorted by first lineage-depleting whole bone marrow from young and aged mice. Samples were
incubated with biotin-conjugated lineage antibodies (CD19, B220, CD4, CD8, CD11b, Gr-1, Ter119, Nk1.1, IL7Ra each at 1:200
dilution), and passaged throughMiltenyi MACS negative selection columns. Cells were subsequently analyzed with aMACSQuant10
Flow Cytometry machine (Miltenyi), or sorted using BD Aria sorter. HSPCs were sorted using SLAMmarkers with the following gating
strategies: for MPPs: Lineage-cKit+Sca1+CD150-CD48+, for ST-HSCs: Lineage-cKit+Sca1+CD150-CD48- and for LT-HSCs:
Lineage-cKit+Sca1+CD150+CD48-, with or without CD61. Gating strategies for other cell types used in our analysis are described
in Figure S8. (Complete list of antibodies catalog numbers and lots can be found in Key Resources Table)
Cell culture
Cells were cultured in a sterile incubator that was maintained at 37C and 5% CO2. Primary cells were cultured in HSPC media,
comprised of complete RPMI supplemented with 10% FBS, 100 U/mL penicillin, 100 U/mL streptomycin, 50uM b-mercaptoethanol
and mouse SCF (50 ng/mL), IL-3 (20 ng/mL), and IL-6 (50 ng/mL) when cultured for reconstitution experiments. 293T cells were
cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 U/mL streptomycin. For in vitro
stimulation, sorted HSPCs were incubated in HSPC media with 100ng/ml LPS (SIGMA CAT: L2880-100MG), and 1ug/ml Pam3csk4
(Invivogen CAT: 41-11-60-10) for the indicated time points.
Bone marrow transplant experiments
Bone marrow reconstitution experiments were performed using aged and young unmanipulated cells or with the vectors noted
below. Aged and young WT CD45.2 C57BL/6 mice were treated with 5-fluorouracil (10ug; Sigma) for 5 days to enrich for hemato-
poietic stem and progenitor cells (HSPCs) in the bone marrow. After 5 days, bone marrow cells were harvested, red blood cells
(RBCs) were lysed with RBC lysis buffer (BioLegend), and cells were plated in HSPC media (see above). Cells were then cultured
for 24 hours and spin-infected for 2 hours at 30C and 2500RPM with PCL-ecotropic pseudotyped gamma-retrovirus expressing
the shRNA or cDNA of interest (see Key Resources table). Virus supernatant was then removed and replaced with HSPC media.
A second round of spin infection was performed 24 hours later. 24hrs after the last infection, recipient mice were lethally irradiated
(1000 rads) and 250,000 virus-infected HSPCs were retro-orbitally delivered to reconstitute the immune system.
Recipientmiceweremonitored for health and peripheral bloodwas analyzed formature blood cell types every 4weeks or at 4 hours
after each LPS injection up till secondary transplant, or till the experimental endpoint 16 weeks post-reconstitution. At each endpoint,
immune organs were harvested for further analysis. The number of mice for each experimental cohort is described in the figure
legends.
For LT-HSC, ST-HSC or MPPs, from either young or aged CD45.2 mice, donor bone marrow was extracted and lineage depleted
cells were sorted for each cell population (see sorting procedure above). Cells were then processed for transplant or stimulated with
LPS and Pam3csk4 as described above for 2 hours prior to transplantation. A total of 1000 sorted cells were injected together with
100,000 supporting CD45.1 bonemarrow cells from young donors into irradiated young CD45.1 recipient mice. For secondary trans-
plant experiments, 250,000-500,000 cells from whole bone marrow of primary transplant mice were transplanted into irradiated
young CD45.1 recipient mice. For CD61 reconstitution experiments, 100 CD61 high or CD61 low LT-HSCs from young or aged
CD45.2 mice were injected into irradiated young CD45.1 mice together with 200,000 supporting total bone marrow cells from young
CD45.1 mice. Each experiment was repeated at least twice, and in many cases three times.
In vivo LPS challenge
Mice were injected intraperitoneally with a sublethal dose of LPS (0.5ug/gram, SIGMA CAT: L2880-100MG), and were bled before
injections, and after 24hrs, 7days, 14days and 7 weeks. Blood samples were analyzed for CD11b, CD3e, CD19, and Gr1 expressing
cells to asses mature immune cell populations. In some cases, a secondary injection of 0.5ug/gram LPS was conducted followed by
immune cell repertoire in peripheral blood as with the first injection. For chronic LPS injections, mice were injected with 0.1ug/gram
twice weekly for 12weeks. Mice were then harvested, blood samples were analyzed for CD11b, CD3e, CD19, and Gr1 expressing
cells to asses mature immune cell populations, and bone marrow cells were analyzed for LT-HSC, ST-HSC, MPP as well as
CD61 on LT-HSCs.
Bulk RNA-seq
For bulk RNA-seq, LT-HSCs, ST-HSCs and MPPs from aged and young mice were sorted as described above. Cells were then
stimulated in vitro for 0.5, 1hr, 2hr, 4hr, 8hr, or 12hr with 100ng/ml LPS (SIGMA CAT: L2880-100MG), and 1ug/ml Pam3CSK4
(Invivogen CAT: 41-11-60-10). mRNA extraction was performed using the PrepEase RNA Spin Kit (usb). RNA quality was assessede3 Cell Reports 25, 2992–3005.e1–e5, December 11, 2018
using RNA 6000 Pico Kit (Agilent). Full-length RNA-seq libraries were prepared as previously described (Kowalczyk et al., 2015) and
paired-end sequenced (38bp x 2) on an Illumina HiSeq2500.
scRNA-seq
For full-length scRNA-seq, LT-HSCs, ST-HSCs and MPPs from aged and young mice were sorted as described above and
stimulated in vitro for 2 hours in large volumes (2000-3000 cells in 10mL of media) to minimize secondary stimulation with secreted
cytokines. Single cells were subsequently sorted into 96 well plates containing 5ul TCL Buffer (QIAGEN) with 1% 2-mercaptoethanol,
centrifuged and frozen at 80C. SMART-Seq2 protocol was carried out as previously described (Picelli et al., 2013) with minor
modifications (M.S.K. and A.R., unpublished data). cDNA was amplified with 20 cycles and tagmented with a quarter of the standard
Illumina NexteraXT reaction volume. Single-cell libraries were pooled and paired-end sequenced (38bp x 2) on an Illumina Hiseq2500
or Nextseq500.
DNA constructs
For in vivo Ikzf1, Klf4, Klf5, Hoxa9, Zbtb4, Stat3 shRNA experiments, themature shRNA sequence was synthesized in themicroRNA-
155 loop-and-arms format (O’Connell et al., 2010) and cloned into the MSCV-eGFP (MG). All shRNA sequences are provided in Re-
agents and Resources. For overexpression of Ikzf1, Klf5, and Stat3, the cDNA of each TF was cloned into a PIG vector (Mayr and
Bartel, 2009) (Addgene plasmid # 21654). All cDNA sequences cloned are provided in Table S5. Virus production is described below.
Virus production
To generate retrovirus for HSPC infection, 106 HEK293T cells were first plated in a 15cm plate. 24 hours later, cells were transfected
with both the pCL-Eco vector and either the MG or PIG vector with the relevant shRNA or cDNA described above for gene delivery.
For transfection, we used BioT (Bioland Scientific) as per the manufacturer’s protocol. 36 hours after transfection, virus was
collected, filtered through a 45uM syringe filter, and used for infection of HSPCs.
QUANTIFICATION AND STATISTICAL ANALYSIS
Bulk RNA-seq analysis
RNA-seq reads for both single cell and bulk were aligned to the mm9 UCSC transcriptome and quantified using RSEM (Bowtie
versions 1.27 and 0.12.7, respectively) (Li and Dewey, 2011). Gene-level counts were TMM-normalized and edgeR (Robinson
et al., 2010) was used to call differentially expressed genes, comparing each time point to time 0, for all cell types and mouse
ages. We also considered baseline differences between cell types and mouse ages. P values were adjusted for multiple hypothesis
testing by Benjamini-Hochberg FDR correction, with FDR < 0.01 considered for subsequent analysis.
Single cell RNA-seq analysis
Cells that had fewer than 2000 genes detected, a lower than 25% rate of reads mapping to the transcriptome, or were undergoing
the cell cycle (Kowalczyk et al., 2015) were excluded from analysis. We also excluded outlier cells from the MPPs group which were
likely caused by cell contamination. To correct for batch issues, the two experimental batches were centered to have the samemean
log(TP100K+1) (hereafter referred to as log(TPM), where TPM stands for ‘transcripts per million’) per gene. PCA was done in R with
scaled, centered log(TPM), using only genes annotated with GO terms we considered important in our system, including cytokine
receptor binding, immune system development, immune system process, inflammatory response, response to cytokine, single-
organism developmental process, stem cell, cell proliferation, and autophagy. The permutationPA function from jackstraw (Chung
and Storey, 2015) was used to select significant PCs and then tSNE (tSNE package, with default parameters) was used to reduce
the data to two dimensions. Density-based clustering was performed (package dbscan, eps = 5, minPts = 20) and the resulting three
clusters were used for subsequent analysis.
Single-cell differential expression and gene signatures
All single-cell differential expression analysis was performed with single cell differential expression (SCDE) (Kharchenko et al., 2014),
considering only genes that had at least 50 reads andwere detected in at least 5 cells. For all signatures, a cell’s signature score is the
weighted sum of log(TPM) of genes, weighted by the direction of the enrichment (either +1 for enriched genes or 1 for depleted
genes).
Stimulated mLT-HSC signature
Genes with a DE FDR < 0.1 when comparing stimulated LT-HSCs in cluster 3 to cluster 2 were defined as the signature of stimulated
myeloid-biased LT-HSCs.
Unstimulated mLT-HSC signature
Genes where bulk RNA-seq data indicated a significant difference (FDR < 0.01) in expression between both aged versus young un-
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commonmLT-HSC signature. Next, a weighted sum of the genes in this common signature was used to score each of the unstimu-
lated LT-HSCs, and the cells were partitioned into two groups on this basis. The centroids of these two groups of cells were used to
initialize k-means clustering (k = 2) of the unstimulated LT-HSCs, performed in PC-space with PCs 2-10 of a PCA of all expressed
genes in unstimulated LT-HSCs only (PC1 was correlated with batch, and so was excluded here). This yielded two new clusters,
similar but distinct from those with which we initialized the k-means clustering algorithm. SCDE was used to identify differentially
expressed genes (FDR < 0.1) between the cells in these two clusters (representing myeloid-biased and non-myeloid-biased unsti-
mulated LTs), yielding an unstimulated myeloid-biased LT signature.
TF motif analysis
Enhancers from diverse mouse blood cells (Lara-Astiaso et al., 2014) were associated with neighboring genes with GREAT (McLean
et al., 2010) and eachwas scanned for themouse and (whenmousewas not available) human TFmotifs fromCIS-BP (Weirauch et al.,
2014) using an implementation of GOMER (Granek and Clarke, 2005), yielding a TF binding score for each TF/enhancer pair. TFs that
distinguish cell subsets were defined as those that best discriminate between enhancers associated with genes that are specific to
the subset compared to enhancers that are associated with non-specific, but expressed genes using the Wilcoxon rank sum test,
yielding an enrichment score (AUROC) and P value. P values were subsequently corrected for multiple hypothesis testing with
FDR correction, considering only those with FDR < 0.1 for subsequent analysis.
Statistical tests
All statistical analysis for the phenotypic data was done in Graphpad Prism software using an unpaired Student’s t test, or a 1-way or
2-way ANOVA. Data is reported as mean ± SEM (statistical test is depicted in each figure legend). Significance measurements were
marked as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, or ns for not significant. P values were corrected for multiple hypothesis testing
by Bonferroni’s multiple comparison test.
Replicate information is indicated in the figure legends.
DATA AND SOFTWARE AVAILABILITY
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